| Literature DB >> 33385486 |
Xiangjie Huang1, Xinping Zhu1, Yun Yu1, Wangyu Zhu2, Libo Jin3, Xiaodong Zhang4, Shaotang Li4, Peng Zou5, Congying Xie4, Ri Cui6.
Abstract
Colorectal cancer (CRC) is the third most common cancer and leading cause of cancer related deaths worldwide. Despite recent advancements in surgical and molecular targeted therapies that improved the therapeutic efficacy in CRC, the 5 years survival rate of CRC patients still remains frustratingly poor. Accumulated evidences indicate that microRNAs (miRNAs) play a crucial role in the progression and metastasis of CRC. Dysregulated miRNAs are closely associated with cancerous phenotypes (e.g. enhanced proliferative and invasive ability, evasion of apoptosis, cell cycle aberration, and promotion of angiogenesis) by regulating their target genes. In this review, we provide an updated overview of tumor suppressive and oncogenic miRNAs, circulatory miRNAs, and the possible causes of dysregulated miRNAs in CRC. In addition, we discuss the important functions of miRNAs in drug resistance of CRC.Entities:
Keywords: Circulatory miRNAs; Colorectal cancer; Drug resistance; miRNA; miRNA dysregulation
Mesh:
Substances:
Year: 2020 PMID: 33385486 DOI: 10.1016/j.canlet.2020.12.025
Source DB: PubMed Journal: Cancer Lett ISSN: 0304-3835 Impact factor: 8.679